QuantumLead homepage Services

You have accessed back-upped version of our site. Please reffer to new home page for a more up-to-date information.

Quantum Drug hit identification tool

Drug Hit Identification Tool calculates the IC50 (Kd, Ki, pKd) value of any protein-ligand complex, docks a small-molecule in the active site of a protein and performs screening a library of compounds against a target-protein or DNA/RNA. Hit Identification Tool consists of three modules: The IC50 module, 2) Ligand Docking and 3) Library Screening modules. Drug Hit Identification Tool can run both in Windows and Linux environments.

Hit Identification overview brochure IC50 (Kd, Ki, pKd) value calctulation, IC50 Prediction, molecular docking software, new inhibitor, docked ligand, molecular interaction analysis techniques, molecular simulation, Software for protein - ligand IC50 values prediction, receptor based protein ligand flexible docking, computational protein binding assay -Prediction of inhibition- IC50 predictor-activity research

Quantum Receptor Based molecular modeling technology is applicable to any resolved 3D macromolecule structure. You can order our molecular docking and virtual screening services based on molecular structure indicated below or purchase Quantum software to do docking study and other research in-house:


PDB ID: 1PY5

Title: Crystal Structure of TGF-beta receptor I kinase with inhibitor

Functional Class: Transferase

Primary citation: Sawyer, J.S.,Beight, D.W.,Britt, K.S.,Anderson, B.D.,Campbell, R.M.,Goodson, T.,Herron, D.K.,Li, H.Y.,McMillen, W.T.,Mort, N.,Parsons, S.,Smith, E.C.,Wagner, J.R.,Yan, L.,Zhang, F.,Yingling, J.M. Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain. Bioorg.Med.Chem.Lett. v14 pp.3581-3584, 2004

Abstract Title: Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain.

Keywords: Inhibitory, Inhibitors, Kinases, (homo, Sandwich, Catalytic, Transforming, Kinase, Kinases,, Cells, Phosphorylase, Adenosine, Kinase;, Proteins, Phosphorylation, Activity, Protein, Activin, Domain, Triphosphate, Factor, Acid, Type, Serine/threonine, Relationship, Transferase(phosphotransferase);, Membrane, Structure-activity, 1py5a1, 1py5a2, D1py5a_, Homo, Human, X-ray, Quinolines, Sulfate, Receptors, (pk-like), Receptor, Amino, Kinase-like, (a+b), Bundle, Beta, Sapiens), Type, Animals, 2-layer, Pyrazoles, Signaling, Mitogen-activated, Mainly, (1py5:a), Concentration, Crystallography, Binding, Cultured, Transferase(phosphotransferase), Enzyme, Protein, Orthogonal, Transmembrane, Alpha, Subunit, Pathway, Sapiens, Beta, Tgf-beta, 4-(3-pyridin-2-yl-1h-pyrazol-4-yl)quinoline, Growth, Designing a ligand - a potential drug candidate, Interact specifically, Selected molecular target, Predict, In-vitro, Estimation, Determinate, Simulator, Lab, Bound, Small molecules faciliate, Modeling, Molecular modelling, Camm, Determination, Perform, Assisted, Computer assisted aided rational drug design, Structure based prediction, Estimate, Binds, 3d models, Coordinates, Measure, In-silico, Mechanisms, Advances, Inhibits, Inhibited, Bio, Biochem, Computational, Altered, Predicted values, Properties, Calculated, Appropriate, Scope, Set, Computing, Blocking, Docked, Virtual screening, Inhibiting, Native, Natural, Computational drug discovery technology, Automated, Limit, Automatic,


 
Quantum Pharmaceuticals
 

Design by Netrider.ru 2004 (c) Quantum Pharmaceuticals 2004-2008 Computer Aided Drug Design & ADMET